Trials / Conditions / Recurrent or Metastatic NPC
Recurrent or Metastatic NPC
3 registered clinical trials studyying Recurrent or Metastatic NPC.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | NPC - AXEL Study : Axitinib-Avelumab NCT04562441 | Chinese University of Hong Kong | Phase 2 |
| Completed | The Efficacy and Safety Study of TORIPALIMAB INJECTION Combined With Chemotherapy for Nasophapyngeal Cancer NCT03581786 | Shanghai Junshi Bioscience Co., Ltd. | Phase 3 |
| Completed | Nasopharyngeal Carcinoma (NPC) Axitinib NCT01249547 | Chinese University of Hong Kong | Phase 2 |